EQT is set to acquire a majority stake in CluePoints, a leading AI-powered software provider for Risk-Based Quality Management (RBQM) and data quality oversight in clinical trials. With this investment, EQT aims to leverage its expertise to cement CluePoints’ position as a global market leader. Summit Partners and Clinimetrics SA, both existing investors, will retain minority stakes. CluePoints has been instrumental in enhancing clinical trial data accuracy and integrity, aiding over 9,500 users and driving more than 1,600 studies. The move aligns with EQT’s strategy to support healthcare technology leaders and foster innovation.

Healthcare, Software, Private Equity,Belgium, Global